GoodRx Announces Date for Third Quarter 2023 Earnings Release and Conference Call
12 Oktober 2023 - 10:05PM
Business Wire
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the
“Company”), a leading resource for healthcare savings and
information, today announced it will release its third quarter 2023
financial results before U.S. markets open on Thursday, November 9,
2023. GoodRx management will also hold a conference call and
webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern
Time) to discuss the results and the Company’s business
outlook.
To access the conference call, please pre-register using this
link. Registrants will receive a confirmation with dial-in details
and a unique passcode required to join. The call will also be
webcast live on the Company’s investor relations website at
https://investors.goodrx.com, where accompanying materials will be
posted prior to the conference call.
Approximately one hour after completion of the live call, an
archived version of the webcast will be available on the Company’s
investor relations website at https://investors.goodrx.com for at
least 30 days.
About GoodRx
GoodRx is a leading resource for healthcare savings and
information that makes healthcare affordable and convenient for all
Americans. We offer consumers free access to transparent and lower
prices for brand and generic medications, affordable and convenient
medical provider consultations via telehealth, and comprehensive
healthcare research and information. Since 2011, we have helped
consumers save over $60 billion and are one of the most downloaded
medical apps over the past decade.
GoodRx periodically posts information that may be important to
investors on its investor relations website at
https://investors.goodrx.com. We intend to use our website as a
means of disclosing material nonpublic information and for
complying with our disclosure obligations under Regulation FD.
Accordingly, investors and potential investors are encouraged to
consult GoodRx’s website regularly for important information, in
addition to following GoodRx’s press releases, filings with the
Securities and Exchange Commission and public conference calls and
webcasts. The information contained on, or that may be accessed
through, GoodRx’s website is not incorporated by reference into,
and is not a part of, this press release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231012336216/en/
Investor Contact GoodRx Whitney Notaro
wnotaro@goodrx.com
Press Contact GoodRx Lauren Casparis
lcasparis@goodrx.com
GoodRx (NASDAQ:GDRX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
GoodRx (NASDAQ:GDRX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024